Form 10-Q Tobira Therapeutics, For: Sep 30
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Wall St futures muted as higher oil prices temper risk appetite after S&P record close
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
Tobira Therapeutics (TBRA) Reports Q3 Loss of $1.22/Share
November 10, 2015 4:40 PM ESTTobira Therapeutics (NASDAQ: TBRA) reported Q3 EPS of ($1.22), versus ($7.29) reported last year.
For earnings history and earnings-related data on Tobira Therapeutics (TBRA) click here.
... More